Monday, June 15, 2026

51st Air Control Squadron Honored for Excellence in Combat Power Development

The 51st Air Control Squadron received the Combat Power Development award for enhancing air surveillance and response capabilities.

Luxury Vs. Famine: North Korea’s Elite Rush To Buy $100 Labubu Toys In The Land Of The Dead

North Korea's Future Reserve café mimics Starbucks, offering Labubu vouchers requiring 100 coffee purchases for redemption.

Trump’s 25% AI Chip Tariff Forces Seoul to Stay Put: What It Signals for Tech Trade

South Korea's Trade Bureau head Yeo Han Koo delays return to assess impact of U.S. tariffs on AI semiconductors and industry cooperation.

Tag: chemotherapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Boryung Begins First Global CDMO Supply of Alimta Through Taiwan Partnership

Boryung Pharmaceutical starts supplying Alimta to Lotus, enhancing global CDMO efforts and addressing chemotherapy drug shortages.

A New Study Suggests Selenium Could Help With One of Chemotherapy’s Most Disruptive Side Effects

A study reveals high-dose selenium can reduce exercise-related dysfunction in ovarian cancer patients undergoing chemotherapy.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.